AmeReGen-ImmunoCure, Inc. engages in the manufacture of cell therapeutics. It offers cellular intravascular targeting agents Cell Pak, which treats advanced cancers, such as lung, breast, prostate and liver, melanoma, sarcoma, and blood. The company was founded in 2000 and is based in Georgetown, Cayman Islands. AmeReGen-ImmunoCure Inc. operates as a subsidiary of AmeReGen BioPharmaceuticals Inc.
